Treatment of mucocutaneous disorders through reversing chronic imflammation and barrier disruption
OwnerCarl Thornfeldt, Edward Pastorinventors
Life of this patent
Estimating the term…
Abstract
Topical administration for humans of formulations selected from one or more certain extracts of fruit and/or seeds of berries, date palm, onion and saw palmetto and one or more metallic moieties of metal selected from boron, vanadium and molybdenum. These formulations treat diseases and conditions including visible extrinsic skin aging, eczematous, papulosquamous, follicular, hyperpigmentation and cornification disorders and keratoses.
Claims6
A cosmeceutical composition for treating one or more mucocutaneous conditions in a patient having skin by topically administering to the patient a therapeutically effective amount of a cosmeceutical composition, said cosmeceutical composition comprising:
- (a) at least one fruit extract selected from the group consisting of date palm fruit, bilberry, elderberry, cranberry, blueberry, saw palmetto berries and onion bulb, said fruit extract in an amount of about 0.01 to 51.00 percent by weight;
- (b) at least one metallic moiety selected from the group consisting of sodium borate, boric acid, boron glycinate, boron gluconate, zinc borate, calcium methaborate, molybdenum citrate, molybdenum malate, molybdenum aspartate, ammonium molybdate, vanadyl sulfate, vanadium aspartate, sodium vanadate and orthovanadate in an amount of about 0.001 to 51.00 percent by weight;
- and
- (c) a pharmaceutically acceptable carrier.
A cosmeceutical composition for treating one or more mucocutaneous conditions in a patient having skin by topically administering to the patient a therapeutically effective amount of said cosmeceutical composition, said cosmeceutical composition comprising:
- (a) at least one fruit extract selected from the group consisting of date palm fruit, bilberry, elderberry, cranberry, blueberry, saw palmetto berries and onion bulb, said fruit extract in an amount of about 0.01 to 51.00 percent by weight;
- (b) at least one metallic moiety selected from the group consisting of sodium borate, boric acid, boron glycinate, boron gluconate, zinc borate, calcium methaborate, molybdenum citrate, molybdenum malate, molybdenum aspartate, ammonium molybdate, vanadyl sulfate, vanadium aspartate, sodium vanadate and orthovanadate in an amount of about 0.001 to 51.00 percent by weight;
- (c) an anti-inflammatory agent, wherein said anti-inflammatory agent comprises at least one agent selected from the group consisting of pyrithiones, menthol, phenol, and resorcinol;
- and
- (d) a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.